Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Lim Clarice |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wolfler, A; Sill, H; Zebisch, A
Loss of RKIP expression is a frequent event in chronic myelomonocytic leukemia and functionally involved in the pathogenesis of this malignancy
ONCOL RES TREAT. 2018; 41: 27-27.
[Oral Communication]
Web of Science
Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Woelfler, A; Sill, H; Zebisch, A
LOSS OF RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN MYELOMONOCYTIC LINEAGE COMMITMENT AND AGGRAVATES THE DEVELOPMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN A MURINE IN-VIVO MODEL
HAEMATOLOGICA. 2017; 102: 148-149.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, P; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wölfler, A; Sill, H; Zebisch, A
RAF kinase inhibitor protein is involved in the development of chronic myelomonocytic leukemia
memo - Magazine of European Medical Oncology. 2017; 10(2):21-21.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]